Cite
HARVARD Citation
Condorelli, R. et al. (2019). Genomic alterations in breast cancer: level of evidence for actionability according to ESMO Scale for Clinical Actionability of molecular Targets (ESCAT). Annals of oncology. pp. 365-373. [Online].